Letters to U.S. Global AIDS Coordinator address global AIDS blueprint

The Center for Global Health Policy's "Science Speaks" blog reports on a letter [.pdf] sent by 12 organizations and institutions to U.S. Global AIDS Coordinator Ambassador Eric Goosby, detailing the ways a U.S. global AIDS blueprint, proposed by Secretary of State Hillary Clinton during the XIX International AIDS Conference in July, can address the concerns of key populations, such as injection drug users and men who have sex with men. The letter is signed by representatives of Johns Hopkins University, amfAR: The Foundation for AIDS Research, the Open Society Foundations, ACT V: The End of AIDS, and others, the blog notes and discusses the letter in detail (Barton, 10/8). The PSI "Impact" blog summarizes a different letter sent by the Global AIDS Policy Partnership (GAPP), comprising 27 organizations, to Goosby addressing the blueprint. According to the blog, "We believe '[t]he Blueprint should be designed to leverage greater global leadership and guide U.S. interaction with the Global Fund to Fight AIDS, Tuberculosis and Malaria and other multilateral and international stakeholders'" (10/2).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Patient-derived organoids: Transforming cancer research and personalized medicine